Q&A: Spinovations, a Pitch Challenge 2022 Finalist, Discusses Improving Spinal Surgery One Screw at a Time
Meet Spinovations, a team from Mount Sinai developing a screwdriver to enable minimally invasive spinal procedures. Spinovations will be pitching this technology at the annual Pitch Challenge on May 5! This team won the Innovation Showcase on April 20, where the Pitch …
Q&A: Meet Tyree Williams, a Pitch Challenge 2022 Finalist Developing a Cement Leakage Prevention System for Spinal Surgeries
Tyree Williams’ team is developing a mortar bone cement system to prevent cement leakage during spinal surgery. Williams will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the Mount Sinai Pitch Challenge? Sign …
Meet Faris Gulamali of CPP.ai, a Pitch Challenge 2022 Finalist
Tune in below as Faris Gulamali describes CPP.ai, a non-invasive real-time artificial intelligence (AI) tool to monitor cerebral perfusion pressure. Gulamali will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the Mount Sinai …
Q&A: Meet Jihan Ryu and Xiaosi Gu of Trustworthy Voice, a Pitch Challenge 2022 Finalist
Jihan Ryu and Xiasi Gu are the co-founders of Trustworthy Voice, an artificial intelligence (AI) platform to track patient-clinician alliance. Ryu and Gu will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the …
Q&A: Meet Jason Adleberg, a Pitch Challenge 2022 Finalist
Get to know Jason Adleberg, who is developing an artificial intelligence (AI) software program to detect aortic aneurysms. Adleberg will be presenting this technology at the Mount Sinai Pitch Challenge on May 5! Have you registered for the Mount Sinai Pitch Challenge? …
Mount Sinai Health System Launches i3 Prism, a Technology Commercialization Fund focused on Female and BIPOC Inventors
i3 Prism aims to bring new health care solutions to patients and society by advancing technologies from women and BIPOC inventors closer to the marketplace. Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, …
Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
Sema4 (NASDAQ: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY recently published a study in Nature Communications using network modeling to identify novel …
Clinical Research Associates GRITT™ Resilience-based Methodology with Significantly Reduced Healthcare Utilization and Opioid Use in Patients with IBD
Research published in Clinical Gastroenterology and Hepatology following 394 IBD patients found significantly improved outcomes with use of GRITT™ methodology, augmenting previous findings Trellus Health plc (AIM: TRLS), which is commercializing a scientifically validated, resilience-based, connected health solution for chronic condition management, …
PreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry Leaders to Commercialize Cancer Risk Stratification Services to Support Better Patient Insights and Outcomes
Services Improve the Information Available to Oncologists and Pathologists in Determining Patient Risk Profiles and Treatment Diagnostic Industry Veteran Wayne Brinster Joins as CEO PreciseDx, the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, …